Schedule 13G ownership disclosure
Akari Therapeutics Plc
Security class unavailable · CUSIP: 00972G108
Event date: 2020-07-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.8900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-185791
- Form type
- SC 13G
- Filer
- Akari Therapeutics Plc
- CIK
- CIK 1541157
- Filed
- Jul 02, 2020
- Reporting period
- Jul 01, 2020
- Description
- Schedule 13G beneficial ownership